Table 4

- Association between study variables and study participant’s HbA1c awareness.

VariablesGlycemic controlχ2-valueP-valueUn adjusted OR (95% CI)
YesNo
n (%)
Age groups (in years)
≤5051 (25.4)150 (74.6)4.490.1061.74 (1.03-2.92)
51-6038 (20.5)186 (79.5)1.32 (0.78-2.22)
>6027 (16.4)138 (83.6)1.0 (ref.)
Gender
Male29 (15.5)158 (84.5)4.940.0261.0 (ref.)
Female97 (23.5)316 (76.5)1.67 (1.06-2.64)
Education level
No school attended51 (23.0)171 (77.0)12.380.0301.0 (ref.)
Primary school14 (14.1)85 (85.9)0.55 (0.29-1.05)
Secondary school9 (12.7)62 (87.3)0.49 (0.23-1.05)
Tertiary school20 (21.5)73 (78.5)0.92 (0.51-1.65)
University or college25 (25.3)74 (74.7)1.13 (0.65-1.96)
Master/PhD7 (43.8)9 (56.3)2.61 (0.92-7.35)
Location of residency
Riyadh25 (14.3)150 (85.7)6.710.0101.0 (ref.)
Outside Riyadh101 (23.8)324 (76.2)1.87 (1.16-3.02)
Monthly income
<500034 (16.0)178 (84.0)29.56<0.00011.0 (ref.)
5000-1000030 (14.3)180 (85.7)0.87 (0.51-1.49)
10001-1500040 (33.9)78 (66.1)2.68 (1.58-4.56)
>1500022 (36.7)38 (63.3)3.03 (1.60-5.75)
Duration of diabetes (in years)
≤10107 (32.7)220 (67.3)59.52<0.00016.50 (3.86-1.94)
>1019 (7.0)254 (93.0)1.0 (ref.)
Type of treatment
No treatment3 (50.0)3 (50.0)70.20<0.000114.5 (2.68-78.54)
Diet only10 (47.6)11 (52.4)13.18 (4.78-36.31)
Tablets only90 (33.3)180 (66.7)7.25 (3.99-13.18)
Insulin only9 (10.5)77 (89.5)1.69 (0.70-4.08)
Tablets and insulin14 (6.5)203 (93.5)1.0 (ref.)
Number of follow-up visits
≤3118 (20.6)455 (79.4)1.270.2601.0 (ref.)
>38 (29.6)19 (70.4)1.62 (0.69-3.80)
Awareness of HbA1c
Good97 (36.3)170 (63.7)68.14<0.00015.98 (3.79-9.43)
Not good29 (8.7)304 (91.3)1.0 (ref.)
Educated on meaning of HbA1c
Yes81 (35.5)147 (64.5)46.77<0.00014.0 (2.65-6.05)
No45 (12.1)327 (87.9)1.0 (ref.)
Educated on the target of HbA1c
Yes88 (35.1)163 (64.9)51.42<0.00014.42 (2.89-6.76)
No38 (10.9)311 (89.1)1.0 (ref.)
Heard of HbA1c
Yes115 (5.6)334 (74.4)22.88<0.00014.38 (2.29,8.39)
No11 (7.3)140 (92.7)1.0 (ref.)

HbA1c: hemoglobin A1c, CI: confidence interval, OR: odds ratio, ref.: reference